Prot#RNHE2041: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/17/18 → 9/17/22

Funding

  • TMC Pharma Services Ltd. (Prot#RNHE2041 // Prot#RNHE2041)
  • Salix Pharmaceuticals, Inc. (Prot#RNHE2041 // Prot#RNHE2041)